09
October
2024
|
13:32 PM
America/New_York

Urology Clinical Trial and Prostate Health

Daniel-B-Rukstalis-MD_20220913_IMG_1975_0001

Dr. Rukstalis, a highly respected urologist and surgeon scientist, has spent his career focused on offering cutting-edge care and treatments to improve the well-being of his patients. As one of two lead investigators in the Expander-2 clinical trial, he is spearheading research on an innovative surgical approach for treating lower urinary tract symptoms caused by Benign Prostatic Hyperplasia (BPH). This condition affects many men as they age, and the trial offers hope for more effective relief.
If you're curious to learn more about prostate health and how BPH impacts the body, we invite you to explore this Health and Wellness article, which provides deeper insight into these topics. For those interested in the details of the Expander-2 clinical trial, additional information is available on our Clinical Trials page.